Income StatementBalance SheetCash FlowSegments
Elevance Health logo

Elevance Health Income Statement

Revenue, expenses, and profitability over time

Elevance Health generated $200.42B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $5.2B with a 2.62% net margin. Diluted EPS is $23.58, which declined 0.1% year-over-year. Based on the Q1 2026 filing.

Total Revenue (TTM)$200.42BGross Profit (TTM)$178.76BNet Income (TTM)$5.2BEps Diluted (TTM)$23.58
Latest FilingQ1 2026
Report Date2026-04-22
Market Cap$84.2B
P/E Ratio16.06
ROE12.14%

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Common Stock Dividends Per Share Declared—$1.7$1.7$1.7—$1.7
Common Stock Dividends Per Share—$1.7$1.7$1.7—$1.7
Dividends per share declared—$1.7$1.7$1.7—$1.7
Dividends per share declared—$1.7$1.7$1.7—$1.7
Common Stock Dividends Per Share Declared—$1.7$1.7$1.7—$1.7
Amortization of capitalized software and acquired intangible assets$180.0M$155.0M$147.0M$162.0M$164.0M$112.0M
Benefits, Losses and Expenses$44.8B$46.1B$47.5B$49.3B$49.5B$47.9B
Dividends declared (in dollars per share)—$1.7$1.7$1.7—$1.7
Net Investment Income$527.0M$590.0M$486.0M$625.0M$493.0M$765.0M
Net losses on financial instruments-$74.0M-$464.0M-$131.0M-$1.0M-$57.0M-$78.0M
Operating revenue - total$45.0B$48.8B$49.4B$50.1B$49.3B$49.5B
Common Stock Dividends Per Share Declared—$1.7$1.7$1.7—$1.7
Common Stock Dividends Per Share Declared—$1.7$1.7$1.7—$1.7

Earnings Per Share

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Common Stock Dividends Per Share Declared—$1.7$1.7$1.7—$1.7
Common Stock Dividends Per Share (Declared)—$1.7$1.7$1.7—$1.7
Common Stock Dividends Per Share Declared—$1.7$1.7$1.7—$1.7
Basic earnings per share$1.87$9.64$7.74$5.32$2.55$8.03
Diluted earnings per share$1.87$9.61$7.72$5.32$2.54$8.00
Common Stock Dividends Per Share Declared—$1.7$1.7$1.7—$1.7
Dividends Per Share Declared—$1.7$1.7$1.7—$1.7
Common Stock Dividends Per Share Declared—$1.7$1.7$1.7—$1.7
Common Stock Dividends Per Share Declared—$1.7$1.7$1.7—$1.7
Common stock dividends per share declared—$1.7$1.7$1.7—$1.7
Dividends Per Share Declared—$1.7$1.7$1.7—$1.7
Dividends per share declared—$1.7$1.7$1.7—$1.7
Common Stock Dividends Per Share Declared—$1.7$1.7$1.7—$1.7
Dividends per share declared—$1.7$1.7$1.7—$1.7
Dividends per share declared—$1.7$1.7$1.7—$1.7
Dividends per Share Declared—$1.7$1.7$1.7—$1.7
Common Stock Dividends Per Share Declared—$1.7$1.7$1.7—$1.7
Common Stock Dividends Per Share Declared—$1.7$1.7$1.7—$1.7
Common stock dividends per share declared—$1.7$1.7$1.7—$1.7
Common Stock Dividends Per Share Declared—$1.7$1.7$1.7—$1.7
Common Stock Dividends Per Share Declared—$1.7$1.7$1.7—$1.7
Common stock dividends per share declared—$1.7$1.7$1.7—$1.7

Operating Expenses

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Amortization of Finite-Lived Intangible Assets$180.0M$155.0M$147.0M$162.0M$164.0M$112.0M
Amortization expense$180.0M$155.0M$147.0M$162.0M$164.0M$112.0M
Selling, general and administrative$4.8B$5.3B$5.0B$5.3B$5.4B$6.3B

Net Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Common Dividends Declared (Per Share)—$1.7$1.7$1.7—$1.7
Net income$418.0M$2.2B$1.7B$1.2B$547.0M$1.8B

Operating Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Gross profit$39.4B$43.9B$44.5B$45.3B$44.2B$44.7B

Income Before Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income before income taxes$606.0M$2.8B$2.3B$1.4B$215.0M$2.3B

Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income tax expense$193.0M$613.0M$548.0M$219.0M—$544.0M

Other Income & Expense

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Interest expense$340.0M$344.0M$341.0M$351.0M$366.0M$357.0M

Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net premiums earned$36.2B$40.9B$41.3B$41.8B$40.7B$41.0B
Net investment income$527.0M$590.0M$486.0M$625.0M$493.0M$765.0M
Total revenue$45.4B$48.9B$49.8B$50.7B$49.7B$50.2B

Cost of Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total cost of revenue$6.0B$5.0B$5.3B$5.4B$5.5B$5.5B
Medical costs$33.5B$35.3B$36.7B$38.1B$38.1B$35.6B